Increased glycosylphosphatidylinositol‐anchored protein‐deficient granulocytes define a benign subset of bone marrow failures in patients with trisomy 8. (4th February 2015)
- Record Type:
- Journal Article
- Title:
- Increased glycosylphosphatidylinositol‐anchored protein‐deficient granulocytes define a benign subset of bone marrow failures in patients with trisomy 8. (4th February 2015)
- Main Title:
- Increased glycosylphosphatidylinositol‐anchored protein‐deficient granulocytes define a benign subset of bone marrow failures in patients with trisomy 8
- Authors:
- Hosokawa, Kohei
Sugimori, Naomi
Katagiri, Takamasa
Sasaki, Yumi
Saito, Chizuru
Seiki, Yu
Mochizuki, Kanako
Yamazaki, Hirohito
Takami, Akiyoshi
Nakao, Shinji - Abstract:
- <abstract abstract-type="main" id="ejh12484-abs-0001"> <title>Abstract</title> <p>Trisomy 8 (+8), one of the most common chromosomal abnormalities found in patients with myelodysplastic syndromes (MDS), is occasionally seen in patients with otherwise typical aplastic anemia (AA). Although some studies have indicated that the presence of +8 is associated with the immune pathophysiology of bone marrow (BM) failure, its pathophysiology may be heterogeneous. We studied 53 patients (22 with AA and 31 with low‐risk MDS) with +8 for the presence of increased glycosylphosphatidylinositol‐anchored protein‐deficient (GPI‐AP<sup>−</sup>) cells, their response to immunosuppressive therapy (IST), and their prognosis. A significant increase in the percentage of GPI‐AP<sup>−</sup> cells was found in 14 (26%) of the 53 patients. Of the 26 patients who received IST, including nine with increased GPI‐AP<sup>−</sup> cells and 17 without increased GPI‐AP<sup>−</sup> cells, 14 (88% with increased GPI‐AP<sup>−</sup> cells and 41% without increased GPI‐AP<sup>−</sup> cells) improved. The overall and event‐free survival rates of the +8 patients with and without increased GPI‐AP<sup>−</sup> cells at 5 yr were 100% and 100% and 59% and 57%, respectively. Examining the peripheral blood for the presence of increased GPI‐AP<sup>−</sup> cells may thus be helpful for choosing the optimal treatment for +8 patients with AA or low‐risk MDS.</p> </abstract>
- Is Part Of:
- European journal of haematology. Volume 95:Number 3(2015:Sep.)
- Journal:
- European journal of haematology
- Issue:
- Volume 95:Number 3(2015:Sep.)
- Issue Display:
- Volume 95, Issue 3 (2015)
- Year:
- 2015
- Volume:
- 95
- Issue:
- 3
- Issue Sort Value:
- 2015-0095-0003-0000
- Page Start:
- 230
- Page End:
- 238
- Publication Date:
- 2015-02-04
- Subjects:
- Hematology -- Periodicals
Blood -- Diseases -- Periodicals
Blood -- Periodicals
616.15005 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1600-0609 ↗
http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=ejh ↗
http://onlinelibrary.wiley.com/ ↗
http://firstsearch.oclc.org ↗ - DOI:
- 10.1111/ejh.12484 ↗
- Languages:
- English
- ISSNs:
- 0902-4441
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.729700
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 4272.xml